Jun Deng

A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma

Heng Mei, Chenggong Li, Huiwen Jiang et al. · Journal of Hematology & Oncology · 2021 · 225 citations · Full text

Medicine, Immunology, Oncology +16

Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial

Huiwen Jiang, Chenggong Li, Ping Yin et al. · American Journal of Hematology · 2019 · 137 citations · Full text

Medicine, Hematology, Oncology +17

Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy

Huiwen Jiang, Lin Liu, Tao Guo et al. · Annals of Hematology · 2019 · 125 citations · Full text

Life Sciences, Hematology, Immunology +14

Altered Gut Microbiota in Myasthenia Gravis

Dongxu Qiu, Zhiwei Xia, Jun Deng et al. · Frontiers in Microbiology · 2018 · 109 citations · Full text

Life Sciences, Immunology, Microbiology +17

A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial

Chenggong Li, Heng Mei, Yu Hu et al. · Blood · 2019 · 83 citations

Medicine, Hematology, Oncology +16